Factors affecting the development of adverse drug reactions to ß-blockers in hospitalized cardiac patient population.

Mugosa, Snezana; Djordjevic, Natasa; Djukanovic, Nina; Protic, Dragana; Bukumiric, Zoran; Radosavljevic, Ivan; Boskovic, Aneta; Todorovic, Zoran

Mugosa, Snezana; Djordjevic, Natasa; Djukanovic, Nina; Protic, Dragana; Bukumiric, Zoran; Radosavljevic, Ivan; Boskovic, Aneta; Todorovic, Zoran.

Afiliación

Mugosa S; Department of Pharmacotherapy, Faculty of Pharmacy, University of Montenegro; Clinical Trial Department, Agency for Medicines and Medical Devices of Montenegro, Podgorica, Montenegro.
Djordjevic N; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac.
Djukanovic N; High Medical School "Milutin Milankovic", Belgrade.
Protic D; Department of Pharmacology, Clinical Pharmacology and Toxicology.
Bukumiric Z; Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade.
Radosavljevic I; Department of Surgery, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Boskovic A; Clinic for Heart Diseases, Clinical Centre of Montenegro, Podgorica, Montenegro.
Todorovic Z; Department of Pharmacology, Clinical Pharmacology and Toxicology; Department of Clinical Immunology and Allergy, Medical Center "Bezanijska kosa", Belgrade, Serbia.

Patient Prefer Adherence ; 10: 1461-9, 2016.

Article en En | MEDLINE | ID: mdl-27536078

Palabras clave

CYP2D6; adverse drug reactions; pharmacogenetics; ß-blockers

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Patient Prefer Adherence Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google